Anger as Scots patients miss out on ‘breakthrough’ stem cell therapy offered by NHS England – Herald Scotland
BBC News |
Anger as Scots patients miss out on ‘breakthrough’ stem cell therapy offered by NHS England
Herald Scotland LUCY Clarke was facing a “downhill spiral” when she flew to Russia to undergo a cutting edge stem cell transplant. Two years on she says the procedure not only halted her illness in its tracks, but reversed much of the damage inflicted by multiple … MS patient Colin Campbell tells of “bonus time”BBC News |
Orlando Sentinel |
UCF scientists use new tool in Parkinson’s research
Orlando Sentinel CRISPR was first discovered in the immune system of bacteria as a defense mechanism against viruses. By 2013, researchers showed that the system can be used in animal and human cells to target specific stretches of DNA at precise locations to modify … |
Orlando Sentinel |
UCF scientists use new tool in Parkinson’s research
Orlando Sentinel CRISPR was first discovered in the immune system of bacteria as a defense mechanism against viruses. By 2013, researchers showed that the system can be used in animal and human cells to target specific stretches of DNA at precise locations to modify … |
Investor’s Business Daily |
The Cure For Cancer? Look At Your Blood
Investor’s Business Daily He removes a vial of blood and sends it off to a lab where your immune system cells will be reprogrammed to fight cancer. Days or weeks later, the cells are reintroduced to your body. It’s called CAR–T therapy. And what once sounded like a concoction … |
Surrey Now-Leader |
Wheelchair-bound Langley man raising funds for stem cell therapy in Central America
Surrey Now-Leader Logan Van Dyk hopes stem cell operation in Central America will open doors for him — ones that shut abruptly on Aug. 3, 2008. It took seconds for the now 26-year-old Fort Langley resident’s life to change. On that day nearly nine years ago, just after … |
|
Manufacturing of AAV Vectors for Gene Therapy
Genetic Engineering & Biotechnology News The successes seen in a number of clinical studies on viral vector-based gene therapies (AAV, retroviral, and lentiviral vectors) are well documented, with an ever-broadening pipeline of products entering late-phase clinical trials and hopefully … |